Japan PMDA approves Aurion Biotechs novel cell therapy, Vyznova to treat corneal endothelial disease
By, Admin1 min read
Share
Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, announced it has received regulatory approval from Japan
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
